Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

被引：0
|
作者：
Michael A. Kiebish
Jennifer Cullen
Prachi Mishra
Amina Ali
Eric Milliman
Leonardo O. Rodrigues
Emily Y. Chen
Vladimir Tolstikov
Lixia Zhang
Kiki Panagopoulos
Punit Shah
Yongmei Chen
Gyorgy Petrovics
Inger L. Rosner
Isabell A. Sesterhenn
David G. McLeod
Elder Granger
Rangaprasad Sarangarajan
Viatcheslav Akmaev
Alagarsamy Srinivasan
Shiv Srivastava
Niven R. Narain
Albert Dobi
机构：
[1] BERG LLC,Center for Prostate Disease Research, Department of Surgery
[2] Henry Jackson Foundation for the Advancement of Military Medicine,undefined
[3] Uniformed Services University and the Walter Reed National Military Medical Center,undefined
[4] Joint Pathology Center,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
Bayesian networks; Biochemical recurrence; Biomarkers; Metabolomics; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
    Kiebish, Michael A.
    Cullen, Jennifer
    Mishra, Prachi
    Ali, Amina
    Milliman, Eric
    Rodrigues, Leonardo O.
    Chen, Emily Y.
    Tolstikov, Vladimir
    Zhang, Lixia
    Panagopoulos, Kiki
    Shah, Punit
    Chen, Yongmei
    Petrovics, Gyorgy
    Rosner, Inger L.
    Sesterhenn, Isabell A.
    McLeod, David G.
    Granger, Elder
    Sarangarajan, Rangaprasad
    Akmaev, Viatcheslav
    Srinivasan, Alagarsamy
    Srivastava, Shiv
    Narain, Niven R.
    Dobi, Albert
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [2] SERUM BIOMARKERS FOR PROGNOSIS OF DISEASE PROGRESSION IN PROSTATE CANCER USING MULTI-OMICS
    Kiebish, Michael
    Cullen, Jennifer
    Mishra, Prachi
    Srinivasan, Alagarsamy
    Rosner, Inger
    McLeod, David
    Ali, Amina
    Rodrigues, Leonardo
    Akmaev, Viatcheslav
    Sarangarajan, Rangaprasad
    Narain, Niven
    Dobi, Albert
    Srivastava, Shiv
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E409 - E409
  • [3] Multi-omic profiling of prostate cancer evolution in 39 patients
    Zhong, Qing
    Guo, Tiannan
    Toussaint, Nora
    Wagner, Ulrich
    Charmpi, Konstantina
    Calzone, Laurence
    Beyer, Andreas
    Aebersold, Ruedi
    Wild, Peter J.
    [J]. CANCER RESEARCH, 2017, 77
  • [4] ESTIMATION OF THE EFFECT OF SURROGATE MULTI-OMIC BIOMARKERS
    Fuady, Angga M.
    El Bouhaddani, Said
    Uh, Hae-Won
    Houwing-Duistermaat, Jeanine
    [J]. THEORETICAL BIOLOGY FORUM, 2021, 114 (01) : 59 - 73
  • [5] Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data
    Marco Pellegrini
    [J]. Scientific Reports, 13
  • [6] Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data
    Pellegrini, Marco
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] A multi-omic machine learning analysis to predict ALS disease progression
    Patel, Devanshi
    Sharma, Rhiya
    Jafarpour, Laleh
    Sheppard, Ashlyn
    Shen, Jie
    Chai, Charles
    [J]. MUSCLE & NERVE, 2022, 66 : S14 - S15
  • [8] Multi-omic network signatures of disease
    Gibbs, David L.
    Gralinski, Lisa
    Baric, Ralph S.
    McWeeney, Shannon K.
    [J]. FRONTIERS IN GENETICS, 2014, 4
  • [9] Multi-omic diagnostics of prostate cancer in the presence of benign prostatic hyperplasia
    Spick, Matt
    Muazzam, Ammara
    Pandha, Hardev
    Michael, Agnieszka
    Gethings, Lee A.
    Hughes, Christopher J.
    Munjoma, Nyasha
    Plumb, Robert S.
    Wilson, Ian D.
    Whetton, Anthony D.
    Townsend, Paul A.
    Geifman, Nophar
    [J]. HELIYON, 2023, 9 (12)
  • [10] A multi-omic landscape of steatosis-to-NASH progression
    Liping Xiang
    Xiaoyan Li
    Yunchen Luo
    Bing Zhou
    Yuejun Liu
    Yao Li
    Duojiao Wu
    Lijing Jia
    PeiWu Zhu
    MingHua Zheng
    Hua Wang
    Yan Lu
    [J]. Life Metabolism., 2022, 1 (03) - 257
12345